Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma: a real-life report.
Langrand-Escure J, Vallard A, Rivoirard R, Méry B, Guy JB, Espenel S, Trone JC, Ben Mrad M, Diao P, Rancoule C, Suchaud JP, Fournel P, Guillot A, Chargari C, Escudier B, Négrier S, Magné N. Langrand-Escure J, et al. Among authors: fournel p. Anticancer Drugs. 2016 Jun;27(5):427-32. doi: 10.1097/CAD.0000000000000349. Anticancer Drugs. 2016. PMID: 27045782
[Best practice guide for radiation therapy of non-small cell bronchial cancers].
Martel-Lafay I, Fourneret P, Ayadi M, Brun O, Buatois F, Carrie C, Chilles A, Claude L, Cottin-Durrleman G, Farsi F, Fournel P, Mongodin B, Pouchard I, Balestrière V, Suchaud JP. Martel-Lafay I, et al. Among authors: fournel p. Cancer Radiother. 2009 Jan;13(1):55-60. doi: 10.1016/j.canrad.2008.05.001. Epub 2008 Nov 28. Cancer Radiother. 2009. PMID: 19041270 Review. French.
First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma: data on safety and efficacy.
Chargari C, Pacaut C, Le Moulec S, Moriceau G, Moussaid Y, Rivoirard R, Dulou R, Jacob J, Guy JB, Bauduceau O, Ceccaldi B, Védrine L, Fournel P, Magné N. Chargari C, et al. Among authors: fournel p. Anticancer Drugs. 2013 Aug;24(7):736-42. doi: 10.1097/CAD.0b013e328360974d. Anticancer Drugs. 2013. PMID: 23542752
Radiotherapy for head and neck cancer in nonagenarian patients: a possible cornerstone?
Rivoirard R, Moncharmont C, Assouline A, Auberdiac P, Mery B, Falk AT, Annède P, Trone JC, Guy JB, Vial N, Fournel P, Merrouche Y, Chargari C, Magné N. Rivoirard R, et al. Among authors: fournel p. Eur Arch Otorhinolaryngol. 2015 Mar;272(3):719-25. doi: 10.1007/s00405-014-3017-3. Epub 2014 Apr 2. Eur Arch Otorhinolaryngol. 2015. PMID: 24691850
Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study).
Rivoirard R, Falk AT, Chargari C, Guy JB, Mery B, Nuti C, Peoc'h M, Forest F, Garin C, Adjabi A, Hoarau D, Kawaye S, Almokhles H, Fournel P, Magné N. Rivoirard R, et al. Among authors: fournel p. Clin Oncol (R Coll Radiol). 2015 Aug;27(8):486-7. doi: 10.1016/j.clon.2015.04.003. Epub 2015 May 8. Clin Oncol (R Coll Radiol). 2015. PMID: 25963856 No abstract available.
Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting.
Sassier M, Dugué AE, Clarisse B, Lesueur P, Avrillon V, Bizieux-Thaminy A, Auliac JB, Kaluzinski L, Tillon J, Robinet G, Le Caer H, Monnet I, Madroszyk A, Boza G, Falchero L, Fournel P, Egenod T, Toffart AC, Leiber N, Do P, Gervais R. Sassier M, et al. Among authors: fournel p. Lung Cancer. 2015 Aug;89(2):161-6. doi: 10.1016/j.lungcan.2015.05.005. Epub 2015 May 15. Lung Cancer. 2015. PMID: 26037036
182 results